Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Ann Rheum Dis. 2019 Jan 5;78(3):406–412. doi: 10.1136/annrheumdis-2018-214603

Table 4.

Multivariable logistic regression (adjusted OR, 95% CI) evaluating the odds of belonging to the Head and Neck-Limited group based on selected covariates (derivation cohort)

Covariate ‘Head and Neck-Limited’ versus ‘Pancreato-Hepato-Biliary’ ‘Head and Neck-Limited’ versus ‘Retroperitoneum and Aorta’ ‘Head and Neck-Limited’ versus ‘Mikulicz and Systemic’
Female 1 1.60 (5.39 to 24.98) 10.35 (4.63 to 23.15) 9.24 (3.53 to 24.20)
Asian 6.68 (2.82 to 15.79) 7.43 (2.97 to 18.56) 6.27 (2.27 to 17.29)
Age at diagnosis (per 5 years) 0.78 (0.67 to 0.89) 0.85 (0.74 to 0.98) 0.80 (0.68 to 0.95)
Time to diagnosis (per year) 1.41 (1.19 to 1.66) 1.14 (1.04 to 1.26) 1.12 (0.99 to 1.25)
Serum IgG4 concentration (per 100 mg/dL) 1.03 (0.96 to 1.11) 1.20 (1.05 to 1.36) 0.90 (0.84 to 0.96)

IgG4-RD, IgG4-related disease.